Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion.
Ansuman T SatpathyJeffrey M GranjaKathryn E YostYanyan QiFrancesca MeschiGeoffrey P McDermottBrett N OlsenMaxwell R MumbachSarah E PierceM Ryan CorcesPreyas ShahJason C BellDarisha JhuttyCorey M NemecJean WangLi WangYifeng YinPaul G GiresiAnne Lynn S ChangGrace X Y ZhengWilliam J GreenleafHoward Y ChangPublished in: Nature biotechnology (2019)
Understanding complex tissues requires single-cell deconstruction of gene regulation with precision and scale. Here, we assess the performance of a massively parallel droplet-based method for mapping transposase-accessible chromatin in single cells using sequencing (scATAC-seq). We apply scATAC-seq to obtain chromatin profiles of more than 200,000 single cells in human blood and basal cell carcinoma. In blood, application of scATAC-seq enables marker-free identification of cell type-specific cis- and trans-regulatory elements, mapping of disease-associated enhancer activity and reconstruction of trajectories of cellular differentiation. In basal cell carcinoma, application of scATAC-seq reveals regulatory networks in malignant, stromal and immune cells in the tumor microenvironment. Analysis of scATAC-seq profiles from serial tumor biopsies before and after programmed cell death protein 1 blockade identifies chromatin regulators of therapy-responsive T cell subsets and reveals a shared regulatory program that governs intratumoral CD8+ T cell exhaustion and CD4+ T follicular helper cell development. We anticipate that scATAC-seq will enable the unbiased discovery of gene regulatory factors across diverse biological systems.
Keyphrases
- single cell
- transcription factor
- rna seq
- genome wide
- basal cell carcinoma
- high throughput
- gene expression
- induced apoptosis
- dna damage
- endothelial cells
- cell cycle arrest
- high resolution
- dna methylation
- small molecule
- induced pluripotent stem cells
- oxidative stress
- cancer therapy
- regulatory t cells
- bone marrow
- drug delivery
- depressive symptoms
- binding protein
- mesenchymal stem cells
- cell therapy